**Core tip:** This study aimed to assess the therapeutic potential of *Lactobacillus acidophilus* (LA) for the treatment of pouchitis in a rat model. Rats with pouchitis were randomly divided into three groups: no intervention, normal saline (NS, 3 mL/d normal saline for 7 d), and LA (3 mL/d LA at 1 × 10^10^ colony-forming units for 7 d). General body condition was recorded and pouch specimens were obtained for histological examination. mRNA expression levels of interleukin (IL)-1β, IL-6, IL-10, and tumor necrosis factor-α were determined by RT-PCR. Zonula occludens protein 1 levels were measured by immunohistochemistry.

INTRODUCTION
============

Ulcerative colitis (UC) is defined as a chronic nonspecific inflammatory disorder with recurrent symptoms, involving the mucosa and submucosa of the colon and rectum\[[@B1]\]. Ileal pouch-anal anastomosis (IPAA) is an ideal surgical treatment for UC, allowing complete removal of the colorectal lesion while retaining the anus and avoiding the need for a permanent ileostomy. Ileal pouchitis is a common complication after IPAA in patients with UC, and occurs in approximately 50% of patients\[[@B2]\]. However, the pathogenesis of pouchitis is unclear and basic studies regarding this complication are lacking.

*Lactobacillus acidophilus* (LA) is a gram-positive bacterium that can form a protein crystal layer on the surface of intestinal cells\[[@B3]\], thus conferring a protective effect on the intestinal barrier. The intestinal microbiota are considered to play a vital role in the development of UC\[[@B4]\] and pouchitis. Gionchetti et al\[[@B5]\] demonstrated the efficacy of probiotics such as VSL\#3 for the prophylaxis and treatment of pouchitis, and our results are consistent with the results of this study. However, although various studies have shown beneficial effects of probiotics on the prevention and treatment of pouchitis, the specific mechanism remains unclear. Furthermore, the ability of specific bacteria and their combination to improve pouch inflammation is unknown\[[@B6]\].

Interleukin (IL)-1β is a multi-protein complex, which can play an important role in the maintenance of intestinal immune balance through the identification of bacteria and injury-related molecules\[[@B7]\]. IL-6 is an important inflammatory factor secreted by endothelial cells, macrophages, and mast cells, and participates in the activation of lymphocytes\[[@B8]\]. Tumor necrosis factor (TNF)-α plays a key role in intestinal inflammation, involving multiple immune responses, affecting the expression of endothelial cell adhesion molecules and maintaining intestinal permeability\[[@B9]\]. IL-10 is a regulatory cytokine secreted by mononuclear macrophages and plays an anti-inflammatory role\[[@B10]\]. Intestinal inflammation is often accompanied by abnormalities in inflammatory factors such as IL-1β, IL-6, TNF-α and IL-10, which may reflect the severity of inflammation in pouchitis\[[@B11]\]. Furthermore, damage to the intestinal mucosal barrier is often accompanied by destruction of tight junction proteins, especially the loss of zonula occludens protein-1 (ZO-1), leading to increased intestinal permeability and further increasing the intestinal inflammatory response\[[@B12]\]. Rats subjected to IPAA provide an effective model for the study of pouchitis\[[@B13]\]. Shebani et al\[[@B14]\] established a rat model of dextran sulfate sodium (DSS)-induced pouchitis suitable for further studies of the pathogenesis of the disease.

We investigated the therapeutic effect of probiotic LA in a DSS rat model of ileal pouchitis, including determination of the expression of inflammatory markers (IL-1β, IL-6, TNF-α and IL-10) and ZO-1 protein in the intestinal mucosa by immunohistochemistry.

MATERIALS AND METHODS
=====================

Animals
-------

Male Sprague Dawley rats (*n* = 18) weighing 360-380 g (purchased from the Laboratory Animal Center of the Military Medical Science Academy of the Chinese People's Liberation Army) were housed individually in a specific pathogen-free animal laboratory at a temperature of 25 °C with a 12 h light/dark cycle, and provided with standard rat chow and running water *ad libitum*. Animal care and experiments were conducted according to the international guidelines on animal research and ethics.

Ileal pouchitis model
---------------------

IPAA was performed by microsurgery and pouchitis was induced by administration of 4% DSS for 4 successive days after postoperative day 31. Rats with pouchitis were divided randomly into three groups: no intervention (NI) group, normal saline (NS) group, and LA group (*n* = 6 per group). Rats in the NS group received 3 mL/d normal saline by lavage, and rats in the LA group received 3 mL/d LA at a concentration of 1 × 10^10^ colony-forming units for 7 d by lavage.

General body condition and sample collection
--------------------------------------------

Body weight changes, hematochezia, and fecal scores were observed and recorded in all rats before sacrifice under anesthesia on day 7 after LA or normal saline intervention. Fecal scores were evaluated on a 5-point scale according to the method described by Drzymala-Czyż et al\[[@B15]\]: (1) lack of stool; (2) diarrhea; (3) blob of stool; (4) textured stool; and (5) normal stool. The ileal pouch was harvested after sacrifice and washed with normal saline. Half of each sample was fixed in 10% neutral formalin solution for histological examination and immunohistochemistry, and the remaining portion was immediately frozen in liquid nitrogen and stored at -80 °C for RT-PCR analysis.

Histological assessment of pouchitis tissue
-------------------------------------------

Tissues were paraffin-embedded, stained with hematoxylin and eosin, and examined under a microscope. Pouch specimens were assessed according to the criteria described by Atila et al\[[@B16]\]. Erosion was evaluated as: 0, negative; 1, focal erosion; 2, erosion in many regions; or 3, extensive erosion. Ulceration was evaluated as: 0, none; 1, focal ulceration of the mucosa in half the superficial regions; 2, total mucosal ulceration at multiple foci; or 3, extensive mucosal ulceration extending to the muscularis mucosa or beyond. Intra-epithelial inflammation was evaluated by counting the number of lymphocytes in 100 epithelial cells at the tips of the villi. Villous atrophy was evaluated as: 0, none; 1, mild; 2, moderate; or 3, severe with villous flattening. Edema at the lamina propria was evaluated as: 0, none or 1, positive. Abscess formation and submucosal inflammation were also evaluated.

RT-PCR detection of IL-1β, IL-6, IL-10 and TNF-α mRNA
-----------------------------------------------------

IL-1β, IL-6, IL-10 and TNF-α mRNA were detected using a RT-PCR kit (MJ-RESEARCH, United States) according to the manufacturer's instructions. Total RNA was extracted from pouch tissues using an animal tissue total RNA Extraction Kit (Tiangen, Beijing, China). The primer pairs are shown in Table [1](#T1){ref-type="table"}.

###### 

Primers used for reverse transcription-polymerase chain reaction

              **Oligonucleotide sequence (5'-3')**   **Product length (bp)**
  ----------- -------------------------------------- -------------------------
  IL-1β                                              190
  sense       5'-AATGCCTCGTGCTGTCTGACC-3'            
  antisense   5'-GTGGGTGTGCCGTCTTTCATCA-3'           
  IL-6                                               111
  sense       5'-GACTTCCAGCCAGTTGCCTTCT-3'           
  antisense   5'-TGGTCTGTTGTGGGTGGTATCC-3'           
  IL-10                                              
  sense       5'-GGGTTGCCAAGCCTTGTCAGAA-3'           196
  antisense   5'-CTTCACCTGCTCCACTGCCTTG-3'           
  TNF-α                                              
  sense       5'-GGGCTCCCTCTCATCAGTTCCA-3'           113
  antisense   5'-TGCTCCTCCGCTTGGTGGTT-3'             
  R-GAPDH                                            
  sense       5'-TACCCACGGCAAGTTCAACG -3'            122
  antisense   5'-CACCAGCATCACCCCATTTG -3'            

IL: Interleukin; TNF-α: Tumor necrosis factor-α.

Immunohistochemistry
--------------------

Samples were subjected to immunohistochemistry to assess the expression of ZO-1 protein, using rabbit anti-ZO-1 (PB0072) (Boster, WuHan, China). Immunohistochemical images were analyzed using Image-Pro Plus6.0 software to assess the optical density.

Statistical analysis
--------------------

All statistical analyses were carried out using SPSS 19.0. The data were expressed as the mean ± SD. Data analysis was performed using independent-samples *t*-tests or one-way ANOVA, and comparisons of two among the three groups were made using Students-Newman-Keuls tests. A difference of *P \<* 0.05 was considered statistically significant.

RESULTS
=======

Changes in physiological condition
----------------------------------

Rat body weight decreased linearly after the generation of pouchitis (72.92 ± 6.60). Following intervention for 7 d, body weight in the NI (63.50 ± 5.99) and NS groups (64.67 ± 11.93) continued to decline (Figure [1A](#F1){ref-type="fig"}), with no significant difference between the two groups (*P* \> 0.05). However, the weight of rats in the LA group which initially decreased started to increase again on day 4 of lavage with LA (20.17 ± 3.25). The difference in body weights among the three groups was significant (*F* = 61.34, *P \<* 0.05) (Figure [1B](#F1){ref-type="fig"}).

![Changes in rat body weight during the experiment. A: Body weight changes in rats following pouchitis. Weight in the NI (63.50 ± 5.99) and NS groups (64.67 ± 11.93) continued to decline, while weight in the LA group initially decreased and then increased on day 4 of LA lavage (20.17 ± 3.25); B: The differences in body weight among the three groups were statistically significant (*F* = 61.34, *P \<* 0.05), but there was no significant difference between the NI and NS groups (*P* \> 0.05). NI: No Intervention group; NS: Normal Saline group; LA: *Lactobacillus acidophilus* group.](WJG-23-4735-g001){#F1}

Bloody stools were observed in all groups at the end of the DSS intervention. Hematochezia disappeared in the LA group at 3.17 d ± 0.75 d, and in the NS and NI groups at 6.50 d ± 0.55 d and 6.17 d ± 0.75 d, respectively. The recovery time in the LA group was significantly shorter than in the NS and NI groups (*F* = 108.70, *P \<* 0.05) (Figure [2](#F2){ref-type="fig"}).

![Hematochezia in rats. A: Anal condition of rats in each group at 4 d post-intervention. The NI (a) and NS groups (b) still had hematochezia, but this had disappeared in the LA group (c); B: Recovery was significantly faster in the LA group compared with the NS and NI groups (*F* = 108.70, *P \<* 0.05). NI: No Intervention group; NS: Normal Saline group; LA: *Lactobacillus acidophilus* group.](WJG-23-4735-g002){#F2}

Stools in the NI and NS groups had a similar, loose-paste appearance (Figure [3A](#F3){ref-type="fig"}) and there was no significant difference in fecal scores between the NI (2.67 ± 0.48) and NS groups (2.50 ± 0.51) (*t* = 1.16, *P* \> 0.05). However, feces in the LA group (4.42 ± 0.50) were more normal, and the fecal score was significantly higher than in the NI (*t* = 12.30, *P \<* 0.05) and NS groups (*t* = 13.09, *P \<* 0.05) (Figure [3B](#F3){ref-type="fig"}).

![Feces of rats. A: Stools appeared as loose paste in the NI (a) and NS (b) groups, but were more normal in the LA group (c); B: The fecal score was significantly higher in the LA group compared with the NI (*t* = 12.30, *P \<* 0.05) and NS groups (*t* = 13.09, *P \<* 0.05). NI: No Intervention group; NS: Normal Saline group; LA: *Lactobacillus acidophilus* group.](WJG-23-4735-g003){#F3}

Histopathological changes and pouch scores
------------------------------------------

In terms of gross morphology, mucosal surface congestion and edema, toughness, visible multiple ulcers, and scattered bleeding were observed in the NI and NS groups, but mucosal congestion and edema were less evident in the LA group (Figure [4A](#F4){ref-type="fig"}).

![Gross and microscopic histological observations. A: Mucosal surface congestion and edema, toughness, visible multiple ulcers, and scattered bleeding were evident in the NI (a) and NS (b) groups, but mucosal congestion and edema had disappeared in the LA (c) group; B: Microscopic examination of the pouch revealed irregular and disordered mucosal villi, passivation of the villi, and extensive inflammatory cell infiltration in the central matrix of the villi in the NI (a) and NS (b) groups, but less severe lesions in the LA (c) group; C: There was no significant difference in histological scores between the NI (7.17 ± 0.98) and NS groups (8.00 ± 0.89) (*t* = 1.536, *P* \> 0.05), but the histological score was significantly lower in the LA group (4.00 ± 0.89) than in the other two groups (*F* = 5.84, *P \<* 0.05). NI: No Intervention group; NS: Normal Saline group; LA: *Lactobacillus acidophilus* group.](WJG-23-4735-g004){#F4}

On microscopic examination, the structure of the mucosal villi in the pouch tissue was irregular and disordered, the passivation of the villi, with extensive inflammatory cell infiltration in the central matrix of the villi in the NI and NS groups, while less severe lesions were observed in the LA group (Figure [4B](#F4){ref-type="fig"}). There was no significant difference in histological scores between the NI (7.17 ± 0.98) and NS groups (8.00 ± 0.89) (*t* = 1.536, *P* \> 0.05), but the histological score was significantly lower in the LA group (4.00 ± 0.89) compared with the other two groups (*F* = 5.84, *P \<* 0.05) (Figure [4C](#F4){ref-type="fig"}).

Expression of IL-1β, IL-6, IL-10, and TNF-α mRNA
------------------------------------------------

mRNA levels of IL-1β, IL-6, and TNF-α in the LA group were significantly lower than in the NS and NI groups (*F* = 373.60, *P \<* 0.05; *F* = 285.50, *P \<* 0.05; *F* = 132.90, *P \<* 0.05, respectively). In contrast, IL-10 mRNA levels were significantly higher in the LA group compared with the other two groups (*F* = 61.05, *P \<* 0.05). There was no significant difference in expression levels of inflammatory factors between the NS and NI groups (*P* \> 0.05) (Figure [5](#F5){ref-type="fig"}).

![mRNA expression levels. mRNA levels of IL-1β (A), IL-6 (B), and TNF-α (C) were significantly lower in the LA group compared with the NS and NI groups (*F* = 373.60, *P \<* 0.05; *F* = 285.50, *P \<* 0.05; *F* = 132.90, *P \<* 0.05, respectively), while IL-10 (D) levels were significantly higher (*F* = 61.05, *P \<* 0.05). IL: Interleukin; TNF-α: Tumor necrosis factor-α; NI: No Intervention group; NS: Normal Saline group; LA: *Lactobacillus acidophilus* group.](WJG-23-4735-g005){#F5}

Expression levels of ZO-1 protein
---------------------------------

ZO-1 is a tight junction protein, indicated by yellow staining in the cell membrane (Figure [6A](#F6){ref-type="fig"}). ZO-1 protein expression levels were significantly lower in the NI (0.27 ± 0.03) and NS groups (0.22 ± 0.08) compared with the LA group (0.35 ± 0.02) (*F* = 8.23, *P \<* 0.05) (Figure [6B](#F6){ref-type="fig"}).

![Zonula occludens protein 1 protein expression levels. A: ZO-1 protein expression levels in the NI (a, d) and NS groups (b, e) were significantly lower than in the LA group (c, f); B: The differences between the three groups were statistically significant (*F* = 8.23, *P \<* 0.05). ZO-1: Zonula occludens protein 1; NI: No Intervention group; NS: Normal Saline group; LA: *Lactobacillus acidophilus* group.](WJG-23-4735-g006){#F6}

DISCUSSION
==========

The intestinal microflora is generally thought to be involved in the pathogenesis of inflammatory bowel disease (IBD)\[[@B17]\]. The numbers of intestinal *Bifidobacterium* and *Lactobacillus* were decreased and *Clostridium perfringens* was significantly increased in patients with pouchitis\[[@B18]\]. LA is a component of VSL\#3, and VSL\#3, which is beneficial for maintaining remission in patients with pouchitis\[[@B19],[@B20]\]. Probiotics containing LA can reduce expression of the inflammatory cytokine IL-1β and inhibit inflammatory damage caused by infiltration of polymorphonuclear cells in the tissues. Lammers et al\[[@B11]\] suggested that probiotics could be used to prevent and treat pouchitis, and LA has also shown immunomodulatory effects in *in vitro* experiments\[[@B21]-[@B24]\].

NaCl absorption involves coupling of the Cl^-^/HCO^3-^ exchanger(s) primarily with the Na^+^/H^+^ exchanger 3 at the apical membrane of intestinal epithelia. Disturbances to this process occur in diarrheal diseases\[[@B25]\], and may also be involved in the formation of mucus stools in pouchitis. LA-conditioned medium stimulated intestinal cells to absorb NaCl by different mechanisms in *in vitro* experiments, and this mechanism may be an important factor in the improvement and treatment of IBD-associated diarrhea symptoms\[[@B26],[@B27]\]. Borthakur et al\[[@B26]\] found that LA increased the exchange effect by increasing cell surface phosphoinositide 3-kinase dependent Cl^-^/HCO3^-^ channels. Singh et al\[[@B27]\] showed that LA could promote the expression of Na^+^/H^+^ exchanger 3 (SLC9A3), which is widespread in epithelial cells of the digestive tract, resulting in improved intestinal absorption of electrolytes and an antidiarrheal effect. Chen et al\[[@B28]\] showed that LA was able to prevent bacterial colitis and activate the immune response with a protective effect on the intestinal mucosa.

Changes in intestinal inflammation are often accompanied by abnormalities in a range of inflammatory cytokines, including IL-1β, IL-6, TNF-α and IL-10, and the level of inflammation can be determined by detecting changes in these inflammatory factors in the pouch mucosa\[[@B11]\]. The results showed that the expression levels of IL-1β, IL-6 and TNF-α were significantly higher in patients with pouchitis than in those with active UC and non-pouchitis. Intestinal tract damage can lead to activation of the inflammatory response resulting in activation of caspase-1 and release of IL-1β\[[@B29]\]. Our study found that the expression of IL-1β in pouch tissues was significantly increased after pouchitis was induced by DSS, and compared with the control group, LA can significantly reduce the expression of IL-1β.

IL-6 expression levels were significantly increased in intestinal tissues of rats with inflammation. The interaction of antigen presenting cells with bacteria in IBD patients was shown to result in abnormal activation of CD4^+^ T cells, causing continuous release of pro-inflammatory cytokines and increased levels of IL-6 and TNF-α\[[@B30]\]. Our results showed that the expression levels of IL-6 and TNF-α in the mucosa of DSS-induced pouchitis were significantly higher than those in the control group, while the expression was decreased following LA gavage and the pathological score of the pouch was significantly decreased. Sang et al\[[@B31]\] treated rats with colitis using VSL\#3 and showed that probiotics could significantly reduce IL-6 expression in intestinal tissues. Chen et al\[[@B32]\] also found that LA could significantly inhibit the expression of TNF-α in the intestinal mucosa in a rat colitis model.

IL-10 has previously been shown to play an anti-inflammatory role in pouchitis\[[@B33]\], and LA significantly increased IL-10 expression in human peripheral blood cells\[[@B34]\]. The results of the current study showed that DSS caused an intestinal inflammatory response in rats, associated with significantly increased levels of IL-1β, IL-6, and TNF-α, and significantly decreased levels of IL-10. This is consistent with the results of Chen et al\[[@B35]\], who used probiotics in a DSS-induced pouchitis model in rats. In addition, IL-6 can increase the amount of myeloperoxidase (MPO) by activating neutrophils, the increase in MPO protein not only reflects the degree of inflammation, but can produce a large number of oxygen free radicals in the intestinal barrier and further aggravate intestinal inflammation.

ZO-1 is a member of the membrane-associated guanylate kinases family\[[@B36]\]. Shen et al\[[@B37]\] showed that abnormal tight junctions resulted in increased permeability of the intestinal barrier, often accompanied by decreased expression of ZO-1 protein. Changes in the intestinal barrier caused by reduced ZO-1 expression in the intestinal tract will further promote the development of intestinal inflammation\[[@B12]\]. ZO-1 decreased following DSS administration in a rat colitis model, and the severity of colitis increased with time\[[@B12]\]. Our results also showed that ZO-1 expression levels were significantly higher in the LA group compared with the NI and NS groups, accompanied by decreased expression of inflammatory factors and improved pathological changes.

In summary, DSS-induced destruction of the intestinal barrier in the pouch manifested as increased levels of pro-inflammatory IL-1β, IL-6 and TNF-α, and decreased levels of anti-inflammatory IL-10, together with decreased expression of the intestinal barrier tight junction protein ZO-1. These factors reflect a complex network with the potential to aggravate mucosal inflammation in the pouch. LA may reduce the expression of pro-inflammatory factors and increase anti-inflammatory factors through a variety of mechanisms, increase expression of the tight junction protein ZO-1 in the intestinal mucosa thus promoting recovery of intestinal mucosal barrier function, and block interactions among various pro-inflammatory factors. Further studies are needed to clarify the potential role of LA in the prevention and treatment of pouchitis.
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Ileal pouchitis is a common complication after ileal pouch-anal anastomosis (IPAA) in patients with ulcerative colitis (UC), and occurs in approximately 50% of patients. However, the pathogenesis of pouchitis is unclear and basic studies regarding this complication are lacking. *Lactobacillus acidophilus* (LA) confers a protective effect on the intestinal barrier, but the therapeutic potential of LA on pouchitis is uncertain.

Research frontiers
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Gastrointestinal microbiota in the field of inflammatory bowel disease (IBD) and pouchitis is a hot research topic.

Innovations and breakthroughs
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Flora imbalance is involved in the pathogenesis of IBD, and has a similar role in the genesis and development of pouchitis. The authors confirmed that LA can be effective in the treatment of pouchitis, which provides a new treatment option for pouchitis.

Applications
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This study provides a new treatment option for pouchitis. The successful application of LA in the treatment of pouchitis in rat models has indicated that further research on microbial treatment in humans should be carried out.

Terminology
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Pouchitis: An intestinal pouch complication of the IPAA procedure in patients with UC. Symptoms of pouchitis include diarrhea, hematochezia, increased stool frequency and abdominal cramps. LA: LA is a gram-positive bacterium that can form a protein crystal layer on the surface of intestinal cells, thus conferring a protective effect on the intestinal barrier and plays a vital role in the development of UC and pouchitis.
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